Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Will Guidant Return To Pharma Roots After 10 Years As Stand-Alone Entity?

This article was originally published in The Gray Sheet

Executive Summary

Guidant's cardiac surgery device and guiding catheter segments offer an attractive fit with Johnson & Johnson, though ICD market access and drug-eluting stent synergies would be the true drivers of any merger

You may also be interested in...



J&J Claims Guidant For $23.9 Bil., Forms CV Device Group Under Valeriani

Johnson & Johnson's willingness to pay $24 bil. (6.5-times revenue) for Guidant validates the long-standing claim of ICD manufacturers that the cardiac rhythm management market is largely underserved

Bard To Join Carotid Stent Fray In 2005 With IDE Trial

Bard's decision to enter the carotid stent race in 2005 reflects the firm's confidence that it will become a top player in the emerging field

J&J Claims Guidant For $23.9 Bil., Forms CV Device Group Under Valeriani

Johnson & Johnson's willingness to pay $24 bil. (6.5-times revenue) for Guidant validates the long-standing claim of ICD manufacturers that the cardiac rhythm management market is largely underserved

Related Content

UsernamePublicRestriction

Register

MT021322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel